BrightInsight

Sanofi decided the post-activation patient journey deserved the same rigor as the science that gets patients there. At VivaTech this week, they're showcasing AI working across the full patient journey — including the chapter that most programs leave to chance. BrightInsight is proud to be a featured startup partner in that story, presenting in their connected patient care corner alongside a team that has deployed this at scale across real commercial programs. The pharma industry spent decades perfecting how to get a patient to say yes. Building what comes after — the intelligence to know when someone is drifting, and the ability to act on it — turned out to be the harder problem. That's the one we're solving. Together we can do so much more than treat diseases. We're connecting with patients and supporting them throughout their entire journey, from discovery to ongoing care. Sanofi #vivatech #patientpersistence

Most digital health programs measure surface level engagement — app installs, active usage, or maybe session length. BrightInsight and Sanofi measured whether patients stayed on life-changing therapy — and proved they can. Tomorrow at HLTH Europe, something rare is happening on a conference stage: a global pharma company and their partner are presenting real-world evidence they built, measured and validated together: a commercially deployed program with outcomes data. BrightInsight CEO Kal Patel, M.D., MBA and Sanofi's Pius S. Hornstein, MSc, PhD, Global Head of Digital Business Units, take the Life Sciences Track Stage 2 at 3:50pm on Tuesday. Together, they’ll share what integrating the full post-activation patient journey actually produces at scale. If you're in Amsterdam, it's worth the walk across the floor. #hltheurope #patientpersistence

71 out of every 100 patients your brand activated are off their life-changing therapy before year one is up. The pharma industry loses more than $600 billion annually to medication nonadherence and poor persistence. But the conversation about that number almost always focuses on the dollar figure and stops there. The harder question is: where exactly does it happen, and why does nobody see it coming? It happens in the post-activation window — after the onboarding call, after the first fill, after the hub hands off. That's the moment when insights go dark for the brand team. There's no real-time signal when a patient starts drifting, no early warning before a discontinuation call, and nothing to indicate a problem until the patient is already gone. The science worked, but the support system didn't. We wrote about pharma's leaky bucket — what it is, why it persists, and what it actually costs. Link is in comments. #patientpersistence #patientservices #patientsupportprogram

For patients in their 70s and 80s managing macular disease, the assumption has been that digital monitoring won't stick. A year of real-world data from Stanford Health Care just changed that. Over 12 months, Theodore Leng, MD, MS at Stanford's Byers Eye Institute followed 118 patients with macular disease — median age 74, with patients ranging into their 90s — who were prescribed the myVisionTrack (mVT) app for at-home vision monitoring. Here’s what the data showed: →  More than 80% of registered patients were still active at 12 months →  57–66% consistently completed 8+ tests per month →  Patients who used the in-app reminder tested 20% more frequently →  Most tested both eyes in under 5 minutes, on their own devices The primary drop-off wasn't sustained disengagement — it was the window between prescription and the first test. Patients who cleared that threshold kept going. Dr. Leng is presenting the 12-month data at ARVO today. Link to the press release in comments. #ARVO2026  #RetinalHealth  #PatientEngagement  #mVT

🚀 Big news at BrightInsight! I'm excited to share that Tien Lai joined BrightInsight this Monday as our new Senior Director, Quality & Regulatory Compliance. Tien brings deep expertise across regulated digital health, MedTech, and SaaS compliance — and a proven track record of building Quality and Regulatory programs that scale with the business rather than slow it down. That's exactly the kind of leadership we need as we expand our platform and deepen partnerships with the world's leading biopharma companies. In her role, Tien will own BrightInsight's Quality and Regulatory strategy and execution end-to-end, including our best-in-class Quality Management System (QMS). She'll ensure our processes and platform meet customer specifications and align with global standards, regulations, and guidance — and she'll drive the roadmap for global regulatory compliance, including submissions to the FDA and international authorities. Tien joins an exceptional leadership team on this next chapter of her journey → https://lnkd.in/eaWK32bG Kal Patel, M.D., MBA; Robert Zdon; Andrew Schultz; Nicole Warshauer; Ashish Agrawal; Leigh Wager; Candice Creighton; Mallory Norton (Homb), CPA We couldn't be more thrilled to have her on board. Onward! 💡 #DigitalHealth #MedTech #Leadership #RegulatoryCompliance #BrightInsight

Today, we are so proud to announce an exclusive global alliance with Havas Health Network, designating them as our single global agency partner. The pharmaceutical industry loses $500 billion annually due to poor patient adherence and persistence. To solve this, pharma needs more than fragmented apps; brands need a scalable solution paired with world-class healthcare strategy. By integrating our compliant, "always-on" technology with Havas Health’s deep strategic influence, we are delivering exactly that: a pre-vetted, regulatory-ready engine that helps patients start and stay on life-changing therapies. Watch our CEO, Kal Patel, M.D., MBA break down why this alliance is the key to fixing the post-prescription drop-off. 👇 Read the full press release in the comments below.

More fuel. More talent. Same mission. 🚀 Big things continue to happen at BrightInsight! We’re doubling down on our vision with two major announcements: 💰 $13M Funding Round – closed and ready to fuel our 2026 roadmap. 🤝 Executive Team Expansion – welcoming Robert Zdon as Chief Operating Officer, Eric Redline as Senior Vice President of Market Development and Customer Success, and Leigh Wager as Vice President of Product. This combination of resources and expertise is exactly what we need to drive BrightInsight’s continued growth and accelerate development of our AI-enabled medication persistence and adherence solutions. We’re grateful to our existing and new investors for their support and we continue to revolutionize digital health for patients, at scale: Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners. Read the full fundraising details here: https://lnkd.in/gJQrafCs Get to know our new leaders here: https://lnkd.in/g6FFrdsV #DigitalFirst #Growth #AI

Better data leads to better outcomes! We are thrilled to share the latest results regarding our digital solution, developed in collaboration with Sanofi. The data is clear: this digital companion tool is driving a significant positive impact on patient treatment adherence and persistence. When patients are empowered with the right digital tools, they are better equipped to stay on track with their treatment journeys. This milestone reinforces our commitment to transforming patient care through proven digital health solutions. Thank you to our incredible partners at Sanofi who share this vision, including: Emmanuel Frenehard, Olivier Charmeil, Pius S. Hornstein, MSc, PhD, Fabrice Bocquillon, Dimitrije Jankovic, Catherine Blanchette, Seth Levenson, Sylvia Park-Ekecs, Nicolas Bouffort, Hao (Howard) Jin, Hubert de Ruty, Christelle Saghbini, Valerie Zabala, PhD Read the full press release here: https://lnkd.in/g2AWePgH #PatientSupport #DigitalFirst #Partnership #Sanofi #BrightInsight

We're packing our bags and getting ready for the HLTH 2025 conference next week! 🚀 Kal Patel, M.D., MBA and Robert Zdon will be in Las Vegas driving dialogue on the future of healthcare technology, customer engagement, and digital health solutions. If you're attending, we'd love to connect - see you there! #HLTH2025 #DigitalHealth #HealthTech #Innovation #Healthcare

Our team at BrightInsight is thrilled to announce the appointment of Stephen Ubl to our Board of Directors! 👏 Stephen brings a wealth of experience in the pharmaceutical industry and digital health. His proven track record and deep knowledge of the health care system will be invaluable as we continue to revolutionize patient care and support with our scalable solutions. ❤️🩹 🚀 Read more here: https://lnkd.in/gQ9h3qHD Welcome, Stephen! #leadership #brightinsight #digitalhealth